延长QT的药物:在CKD中使用的流行率和相关风险
Sophie Liabeuf1,2, Jessica Berdougo-Tritz3, Lucie Augey3
1Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Hospital, Amiens, France.
概括
慢性病 (CKD) 患者因QT延长而面临心脏突然死亡的高风险. 常用于CKD的QT延长药物显著增加了这种风险,特别是对于透析患者.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 临床药理学 临床药理学
背景情况:
- 慢性病 (CKD) 影响全球10%以上的成年人,导致严重的心血管问题.
- 突然心脏病死亡,通常是由于心室节律失常,如torsades de pointes,是CKD患者死亡的主要原因.
- 延长QT间隔,表明心室再极化延迟,是CKD患者心律不整的关键风险因素,无论在透析中还是脱离透析.
研究的目的:
- 批判性地评估QT延长药物在CKD中使用的病理生理学相关性.
- 评估这些药物在CKD患者中的患病率和心血管影响.
- 审查QT延长药物在这个脆弱人群中常见的安全数据.
主要方法:
- 现有文献的叙述性审查.
- 使用美国脏数据系统对药物流行病学研究的分析.
- 评估导致CKD中QT延长的病理生理机制.
主要成果:
- 在CKD中,QT延长是多因素的,涉及电解质转移,心脏重塑,自主功能障碍和药物暴露.
- 由于液体和电解质的快速变化,血液透析患者特别容易受到影响.
- 药物流行病学研究将QT延长药物与透析患者心脏突然死亡风险的增加联系起来.
结论:
- 尽管安全性数据有限,但在CKD患者中广泛使用QT延长药物是一个重大问题.
- 这些药物与CKD中心脏突然死亡的风险增加有关,特别是在透析患者中.
- 进一步的研究和谨慎的处方是有必要的,以减轻使用这些药物的CKD患者的心血管风险.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.9K
01:18Chronic Kidney Disease IV: Nursing Management
321
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
321
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
209
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
209
01:25Chronic Kidney Disease I: Introduction
565
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
565